Identification of fentanyl, alfentanil, sufentanil, remifentanil and their major metabolites in human urine by liquid chromatography/tandem mass spectrometry for doping control purposes

European Journal of Mass Spectrometry

Volumn 11, Issue 4, 2005, Pages 419-427

  Thevis, Mario ^a   Geyer, Hans ^a   Bahr, Daniel ^a   Schänzer, Wilhelm ^a  

^a GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

Author keywords

Collision induced dissociation; Doping; Fragmentation; Liquid chromatography; Mass spectrometry; Opioids; Sport

Indexed keywords

ALFENTANIL; FENTANYL; NARCOTIC ANALGESIC AGENT; PIPERIDINE DERIVATIVE; REMIFENTANIL; SUFENTANIL;

AGED; ARTICLE; CHEMISTRY; FEMALE; HUMAN; METHODOLOGY; MIDDLE AGED; REPRODUCIBILITY; SUBSTANCE ABUSE; URINE; VALIDATION STUDY;

AGED; ALFENTANIL; ANALGESICS, OPIOID; FEMALE; FENTANYL; HUMANS; MIDDLE AGED; PIPERIDINES; REPRODUCIBILITY OF RESULTS; SUBSTANCE ABUSE DETECTION; SUFENTANIL;

EID: 27644577949     PISSN: 14690667     EISSN: None     Source Type: Journal    
DOI: 10.1255/ejms.761     Document Type: Article

References (27)

1. World Anti-Doping Agency (WADA), The 2005 Prohibited List, http://www.wada-ama.org/rtecontent/document/list_ 2005.pdf; 30-03-2005
2. P. Mastronardi and T. Cafiero, "Rational Use of Opioids", Minerva Anestesiol. 67, 332 (2001).
3. W. Jeal and P. Benfield, "Transdermal Fentanyl. A Review of Its Pharmacological Properties and Therapeutic Efficacy in Pain Control", Drugs 53, 109 (1997).
4. L. Mather, "Clinical Pharmacokinetics of Fentanyl and Its Newer Derivatives," Clin. Pharmacokinet. 8, 422 (1983).
5. R.B. Muijsers and A.J. Wagstaff, "Transdermal Fentanyl: An Updated Review of Its Pharmacological Properties and Therapeutic Efficacy in Chronic Cancer Pain Control", Drugs 61, 2289 (2001).
6. L. Latasch and S. Luders, "Transdermal Fentanyl against Postoperative Pain", Acta Anaesthesiol. Belg. 40, 113 (1989).
7. J. Day, M. Slawson, R.A. Lugo and D. Wilkins, "Analysis of Fentanyl and Norfentanyl in Human Plasma by Liquid Chromatography-Tandem Mass Spectrometry Using Electrospray Ionization", J. Anal. Toxicol. 27, 513 (2003).
8. A.K. Valaer, T. Huber, S.V. Andurkar, C.R. Clark and J. DeRuiter, "Development of a Gas Chromatographic-Mass Spectrometric Drug Screening Method for the N-Dealkylated Metabolites of Fentanyl, Sufentanil and Alfentanil", J. Chromatogr. Sci. 35, 461 (1997).
9. K. Selinger, C. Lanzo and A. Sekut, "Determination of Remifentanil in Human and Dog Blood by HPLC with UV Detection", J. Pharm. Biomed. Anal. 12, 243 (1994).
10. T. Goromaru, H. Matsuura, N. Yoshimura, T. Miyawaki, T. Sameshima, J. Miyao, T. Furuta and S. Baba, "Identification and Quantitative Determination of Fentanyl Metabolites in Patients by Gas Chromatography-Mass Spectrometry", Anesthesiology 61, 73 (1984).
11. H. Van Rooy, M. Vermeulen and J. Bovill, "The Assay of Fentanyl and Its Metabolites in Plasma of Patients Using Gas Chromatography with Alkali Flame Ionisation Detection and Gas Chromatography-Mass Spectrometry", J. Chromatogr. 223, 85 (1981).
12. S. Lin, T. Wang, R. Caprioli and B. Mo, "Determination of Plasma Fentanyl by GC-Mass Spectrometry and Pharmacokinetic Analysis", J. Pharm. Sci. 70, 1276 (1981).
13. L. Palleschi, L. Lucentini, E. Ferretti, F. Anastasi, M. Amoroso and G. Draisci, "Quantitative Determination of Sufentanil in Human Plasma by Liquid Chromatography-Tandem Mass Spectrometry", J. Pharm. Biomed. Anal. 32, 329 (2003).
14. K. Pihlainen, K. Grigoras, S. Franssila, R. Ketola, T. Kotiaho and R. Kostiainen, "Analysis of Amphetamines and Fentanyls by Atmospheric Pressure Desorption/Ionization on Silicon Mass Spectrometry and Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry and Its Application to Forensic Analysis of Drug Seizures", J. Mass Spectrom. 40, 539 (2005).
15. W.Z. Shou, X. Jiang, B.D. Beato and W. Naidong, "A Highly Automated 96-Well Solid Phase Extraction and Liquid Chromatography/Tandem Mass Spectrometry Method for the Determination of Fentanyl in Human Plasma", Rapid Commun. Mass Spectrom. 15, 466 (2001).
16. N.H. Huynh, N. Tyrefors, L. Ekman and M. Johansson, "Determination of Fentanyl in Human Plasma and Fentanyl and Norfentanyl in Human Urine Using LC-MS/MS", J. Pharm. Biomed. Anal. 37, 1095 (2005).
17. J. Bender, J. van den Elshout, K. Selinger, G. Broeders, J. Dankers and C. van der Heiden, "Determination of Remifentanil in Human Heparinised Whole Blood by Tandem Mass Spectrometry with Short-Column Separation", J. Pharm. Biomed. Anal. 21, 559 (1999).
18. Y.G. Suh, K.H. Cho and D.Y. Shin, "Total Synthesis of Fentanyl", Arch. Pharm. Res. 21, 70 (1998).
19. W.R. Hammargren and G.L. Henderson, "Analyzing Normetabolites of the Fentanyls by Gas Chromatography/Electron Capture Detection", J. Anal. Toxicol. 12, 183 (1988).
20. A. Casy and M. Huckstep, "Structure-Activity Studies of Fentanyl", J. Pharm. Pharmacol. 40, 605 (1988).
21. V. Kiricojevic, M. Ivanovic, I. Micovic, J. Djordjevic, G. Roglic and L. Dosen-Micovic, "An Optimized Synthesis of a Key Pharmaceutical Intermediate Methyl 4-[(1-Oxopropyl)Ph enylamino]Piperi-Dine-4-Carboxylate", J. Serb. Chem. Soc. 67, 793 (2005).
22. W. Meuldermans, J. Hendrickx, W. Lauwers, R. Hurkmans, E. Swysen, J. Thijssen, P. Timmerman, R. Woestenborghs and J. Heykants, "Excretion and Biotransformation of Alfentanil and Sufentanil in Rats and Dogs", Drug Metab. Dispos. 15, 905 (1987).
23. A. Poklis, "Fentanyl: A Review for Clinical and Analytical Toxicologists", J. Toxicol. Clin. Toxicol. 33, 439 (1995).
24. T.D. Egan, "Remifentanil: An Esterase-Metabolized Opioid", Western J. Med. 166, 202 (1997).
25. T. Egan, H. Lemmens, P. Fiset, D. Hermann, K. Muir, D. Stanski and S. Shafer, "The Pharmacokinetics of the New Short-Acting Opioid Remifentanil (Gi87084b) in Healthy Adult Male Volunteers", Anesthesiology 79, 881 (1993).
26. T. Egan, "Remifentanil Pharmacokinetics and Pharmacodynamics. A Preliminary Appraisal", Clin. Pharmacokinet. 29, 80 (1995).
27. A. Kromidas, Validierung in Der Analytik. Wiley-VCH, Weinheim (1999).